Clinical Trial Update: The Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End Products [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of SGLT-2 inhibitors on advanced glycation end products was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Northwell Health | Conditions: SGLT-2 Inhibitors, Advanced Glycation End Products | Phase 4 | Status: WITHDRAWN